SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-024659
Filing Date
2021-02-17
Accepted
2021-02-17 07:15:21
Documents
16
Period of Report
2021-02-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm217022d1_8k.htm 8-K 16234
2 EXHIBIT 99.1 tm217022d1_ex99-1.htm EX-99.1 20885
3 GRAPHIC image_001.jpg GRAPHIC 149771
4 GRAPHIC image_002.jpg GRAPHIC 256739
5 GRAPHIC image_003.jpg GRAPHIC 140602
6 GRAPHIC image_004.jpg GRAPHIC 127160
7 GRAPHIC image_005.jpg GRAPHIC 157834
8 GRAPHIC image_006.jpg GRAPHIC 143915
9 GRAPHIC image_007.jpg GRAPHIC 111262
10 GRAPHIC image_008.jpg GRAPHIC 86334
11 GRAPHIC image_009.jpg GRAPHIC 125083
12 GRAPHIC image_010.jpg GRAPHIC 133514
13 GRAPHIC image_011.jpg GRAPHIC 92076
14 GRAPHIC image_012.jpg GRAPHIC 332465
15 GRAPHIC image_013.jpg GRAPHIC 489116
16 GRAPHIC image_014.jpg GRAPHIC 177103
  Complete submission text file 0001104659-21-024659.txt   3511212
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-249434 | Film No.: 21642634
SIC: 2834 Pharmaceutical Preparations